SCHEMBL2651973

SCHEMBL2651973

CCOC(=O)NCC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
HSD17B10 Q99714 2/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 4/20 0.44
MGAM O43451 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
EGLN1 Q9GZT9 1/20 0.42
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GLA P06280 1/20 0.40
ACHE P22303 1/20 0.39
ALOX15 P16050 1/20 0.39
SOAT1 P35610 1/20 0.39
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10989954 0.82 ALDH1A1 (0.42) ALDH1A1HSD17B10LMNAGAAMGAM
SCHEMBL23386305 0.82 ACHE (0.50) GLAACHE
SCHEMBL2482646 0.81 GAA (0.59) ALDH1A1HSD17B10GAAMGAMSI
SCHEMBL1912605 0.81 EGLN1 (0.63) ALDH1A1HSD17B10LMNAGAAMGAM
SCHEMBL602822 0.80
SCHEMBL11184401 0.79 ALDH1A1 (0.56) ALDH1A1HSD17B10LMNAGAAMGAM
SCHEMBL12467409 0.79 GAA (0.42) ALDH1A1HSD17B10LMNAGAAMGAM
SCHEMBL9129733 0.79 GAA (0.42) ALDH1A1HSD17B10LMNAGAAMGAM
SCHEMBL7769472 0.79 ALOX15 (0.48) ALDH1A1HSD17B10LMNAGAAMGAM
SCHEMBL7769468 0.79 GAA (0.42) ALDH1A1HSD17B10LMNAGAAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117819927-A Aldehyde-cleaning (water-resistant) gypsum board 贵州兴电石膏有限公司 2024-04-05 CN claimed
CN-114891183-B Aqueous polyurethane modified starch dispersion liquid and preparation method thereof 江西省科学院应用化学研究所 2024-01-26 CN claimed
CN-219743917-U Water-based polyurethane acetone removing device 山东强睿博新材料科技有限公司 2023-09-26 CN claimed
CN-217341452-U Water-based polyurethane de-acetone device 广东裕田霸力科技股份有限公司 2022-09-02 CN claimed
CN-114891183-A Waterborne polyurethane modified starch dispersion liquid and preparation method thereof 江西省科学院应用化学研究所 2022-08-12 CN claimed
CN-107814868-A Novel aqueous acrylic resin/polyurethane compound leather finishing agent prepared by a kind of Pickering emulsion polymerizations 四川大学 2018-03-20 CN claimed
CN-107417882-A A kind of photocuring water-based polyurethane ink binder and preparation method thereof 郑州华普密封材料有限公司 2017-12-01 CN claimed
CN-117819927-A Aldehyde-cleaning (water-resistant) gypsum board 贵州兴电石膏有限公司 2024-04-05 CN disclosed
CN-114891183-B Aqueous polyurethane modified starch dispersion liquid and preparation method thereof 江西省科学院应用化学研究所 2024-01-26 CN disclosed
CN-114891183-B Aqueous polyurethane modified starch dispersion liquid and preparation method thereof 江西省科学院应用化学研究所 2024-01-26 CN disclosed
CN-219743917-U Water-based polyurethane acetone removing device 山东强睿博新材料科技有限公司 2023-09-26 CN disclosed
CN-219743917-U Water-based polyurethane acetone removing device 山东强睿博新材料科技有限公司 2023-09-26 CN disclosed
CN-219743917-U Water-based polyurethane acetone removing device 山东强睿博新材料科技有限公司 2023-09-26 CN disclosed
US-20090143592-A1 Glucagon Antagonists/Inverse Agonists NOVO NORDISK A/S (DK) 2009-06-04 US disclosed
CN-1913776-A Powder formulations BAYER CROPSCIENCE AG (DE) 2007-02-14 CN disclosed
US-20030203946-A1 Glucagon antagonists/inverse agonists NOVO NORDISK A/S (DK) 2003-10-30 US disclosed
US-6548619-B2 Process for the production of polyurethane particles Weidner, Eckhard (DE) 2003-04-15 US disclosed
US-20020049298-A1 Process for the production of polyurethane particles PETERMANN, MARCUS (DE) 2002-04-25 US disclosed
WO-1995022308-A1 METHOD FOR THE DIAGNOSIS AND REDUCTION OF DENTAL CARIES THE ORALIFE GROUP, INC. (CA) 1995-08-24 WO disclosed
CN-87208565-U MEDICAL PLASTIC INFUSION APPARATUS 1988-03-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143592-A1 Glucagon Antagonists/Inverse Agonists GLP1R, GPR119, GCGR ALDH1A1 3968/4885HSD17B10 1174/4885LMNA 3643/4885
US-20030203946-A1 Glucagon antagonists/inverse agonists GLP1R, GPR119, GCGR ALDH1A1 3770/4885HSD17B10 645/4885LMNA 3715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.